NCT07502820
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07502820
Title The POWER Trial: Personalised Dose Optimisation With Adjuvant Tamoxifen Therapy in Breast cancER (POWER)
Acronym POWER
Recruitment Recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors Karolinska Institutet
Indications
Therapies
Age Groups: adult | senior
Covered Countries SWE


No variant requirements are available.